... metabolism in Japanese. Mol Pharmacol 1994;46:594-598. 3. de Morais SM, Goldstein JA, Xie HG, et al: Genetic analysis of the S-mephenytoin polymorphism in a Chinese population. Clin Pharmacol Ther 1995;58:404-411. 4. de Morais SM, Wilkinson GR, Blaisdell J, et al: The major genetic defect responsible...

...: Lipid signaling cascades of orexin/hypocretin receptors. Biochimie 2014;96:158–165. 4. Kukkonen JP, Leonard CS: Orexin/hypocretin receptor signalling cascades. Br J Pharmacol 2014;171:294–313. 5. Leonard CS, Kukkonen JP: Orexin/hypocretin receptor signalling: a functional perspective. Br J...

... (3-PPP) at dopamine receptor sites. Eur J Pharmacol 1983;92:279-283 9. Sakai K, Takahashi Y: Driving and subsidiary behavior of taxi drivers working alternate-day shifts. J Hum Ergol (Tokyo) 1975;4:115-127 10. Baenninger R, Binkley S, Baenninger M: Field observations of yawning and activity...

..., Klebon B, Heinrich U, et al. In vitro sun protection factor: still a challenge with no final answer. Skin Pharmacol Physiol. 2010;23:201–12. 12. Rohr M, Klette E, Kockott D, Jenni K, Bimzcok R, Gers-Barlag H, et al. In vivo and in vitro SPF determination: two sides of the same coin?. IFSCC Magazine...

...References References 1. Tayman C, Rayyan M, Allegaert K: Neonatal pharmacology: extensive interindividual variability despite limited size. J Pediatr Pharmacol Ther 2011;16:170-184. 2. Hines RN: The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol...

.... Wallace JL: Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?. Physiol Rev 2008;88:1547-1565 9. Bjarnason I, Scarpignato C, Rainsford KD: Determinants of the short-term gastric damage caused by NSAIDs in man. Alimen Pharmacol Therap 2007;26:95-106 10...

... Crit Care Med 1998;158:(5, Pt. 3)S154-S60 5. Fernandes LB, Fryer AD, Hirshman CA: M2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle. J Pharmacol Exp Ther 1992;262:(1)119-26 6. Sarria B, Naline E, Zhang Y, et al: Muscarinic M 2 receptors...

...-controlled phase II study of PL 14736 enema in the treatment of mild-to-moderate ulcerative colitis. Gastroenterology 2005;128:A584 7. Keremi B, Lohinai Z, Komora P, et al: Antiinflammatory effect of BPC 157 on experimental periodontitis in rats. J Physiol Pharmacol 2009;60:(suppl 7)115-122 8...

... implications. Annu Rev Pharmacol Toxicol 1996;36:281-306 4. Paul M, Poyan Mehr A, Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev 2006;86:747-803 5. Lavoie JL, Sigmund CD: Minireview: overview of the renin-angiotensin system - an endocrine and paracrine system. Endocrinology...

... Pharmacol Ther 2012;35:5-14. 6. Holzer P: Acid-sensitive ion channels in gastrointestinal function. Curr Opin Pharmacol 2003;3:618-625. 7. Krarup AL, Ny L, Gunnarsson J, et al: Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease...

... characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 2001;59:(3)420-6 3. Morse KL, Behan J, Laz T.M, et al: Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 2001;296:(3)1058-66 4. Nguyen T, Shapiro DA, George SR, et al: Discovery...

... Med Lyon 1942;23:409. 23. Ashford CA, Heller H, Smart GA: The action of histamine on hydrochloric acid and pepsin secretion in man. Br J Pharmacol Chemother 1949;4:153-161. 24. Parsons ME, Ganellin CR: Histamine and its receptors. Br J Pharmacol 2006;147(suppl 1):S127. 25. Folkow B, Haeger...

... contributes to enhanced sympathetic drive in rats with heart failure. J Cardiovasc Pharmacol. 2003;42:S111–S5. 7. Martins-Pinge MC, Garcia MR, Zoccal DB, Crestani CC, Pinge-Filho P. Differential influence of iNOS and nNOS inhibitors on rostral ventrolateral medullary mediated cardiovascular control...

..., Blaisdell J, et al: Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol 1994;46:594-598. 3. de Morais SM, Goldstein JA, Xie HG, et al: Genetic analysis of the S-mephenytoin polymorphism in a Chinese population. Clin Pharmacol...

...: The physiological action of β-iminazolylethylamine. J Physiol 1910;41:318-344. 4. Dale HH: The anaphylactic reaction of plain muscle in the guinea-pig. J Pharmacol 1913;4:167-223. 5. Dale HH, Laidlaw PP: Histamine shock. J Physiol 1919;52:355-390. 6. Best CH, Dale HH, Dudley HW, Thorpe WV: The nature...

...References References 1. Bellanti F, Della Pasqua O: Modelling and simulation as research tools in paediatric drug development. Eur J Clin Pharmacol 2011;67(suppl 1):75-86. 2. Manolis E, Pons G: Proposals for model-based paediatric medicinal development within the current European Union...

...: A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori -associated gastric or duodenal ulcer. Aliment Pharmacol Ther 2001;15:1949-1958. 3. Miwa H, Sakaki N, Sugiyama T, et al: Recurrent peptic ulcers in patients following successful Helicobacter pylori...

... Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 2002;54:219-226 5. Davenport AP, Maguire JJ: Endothelin. Handbk Exp Pharmacol 2006;176:295-329 6. Karet FE, Davenport AP: Localization of endothelin peptides in human kidney. Kidney Int 1996;49:382-387 7...

...: Sex differences in drug disposition. J Biomed Biotechnol 2011;2011:187103 4. Gray J: Why can’t a woman be more like a man?. Clin Pharmacol Ther 2007;82:15-17 5. Uhl K, Parekh A, Kweder S: Females in clinical studies: where are we going?. Clin Pharmacol Ther 2007;81:600-602 6. Andrew MA...

..., Rundfeldt C: Anti-inflammatory potential of the selective phosphodiesterase 4 inhibitor N-(3,5-dichloro-pyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), in human cell preparations. J Pharmacol Exp Ther 2004; 308:(2) 555-63 5. Torphy TJ: Phosphodiesterase isozymes...